Director/PDMR Shareholding

RNS Number : 2117Y

GlaxoSmithKline PLC

13 May 2016

 

        GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc ('GSK') was advised on 13 May 2016 of the following increases in the notional allocation of GSK American Depositary Shares ('ADSs') on 12 May 2016, at a price of $42.07 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401(K) plan:

Director	Number of ADSs
Dr M M Slaoui	18

Connected Person	Number of ADSs
Dr K Slaoui (Connected Person of Dr M M Slaoui)	12

V A Whyte

Company Secretary

13 May 2016

 

END

 

 

DSHKXLBFQEFEBBE